A detailed history of Empire Life Investments Inc. transactions in Omeros Corp stock. As of the latest transaction made, Empire Life Investments Inc. holds 8,959 shares of OMER stock, worth $35,119. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,959
Previous 8,878 0.91%
Holding current value
$35,119
Previous $30,000 20.0%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

BUY
$3.04 - $4.23 $246 - $342
81 Added 0.91%
8,959 $36,000
Q4 2023

Feb 08, 2024

BUY
$1.08 - $3.63 $186 - $627
173 Added 1.99%
8,878 $29,000
Q3 2023

Nov 09, 2023

SELL
$2.81 - $5.69 $281 - $569
-100 Reduced 1.14%
8,705 $25,000
Q2 2023

Aug 10, 2023

BUY
$4.45 - $7.57 $449 - $764
101 Added 1.16%
8,805 $47,000
Q1 2023

May 08, 2023

BUY
$2.48 - $5.22 $461 - $970
186 Added 2.18%
8,704 $40,000
Q4 2022

Feb 02, 2023

SELL
$1.75 - $3.96 $29 - $67
-17 Reduced 0.2%
8,518 $19,000
Q3 2022

Nov 14, 2022

BUY
$3.09 - $7.46 $290 - $701
94 Added 1.11%
8,535 $27,000
Q2 2022

Aug 03, 2022

BUY
$1.92 - $6.28 $364 - $1,193
190 Added 2.3%
8,441 $23,000
Q3 2021

Nov 09, 2021

BUY
$13.4 - $16.3 $428 - $521
32 Added 0.39%
8,251 $114,000
Q2 2021

Aug 04, 2021

BUY
$14.81 - $19.13 $1,436 - $1,855
97 Added 1.19%
8,219 $122,000
Q1 2021

Apr 29, 2021

SELL
$14.52 - $23.53 $2.22 Million - $3.6 Million
-152,919 Reduced 94.96%
8,122 $145,000
Q4 2020

Feb 09, 2021

BUY
$10.14 - $15.19 $447,366 - $670,167
44,119 Added 37.73%
161,041 $2.3 Million
Q3 2020

Nov 05, 2020

BUY
$9.57 - $21.32 $1.12 Million - $2.49 Million
116,922 New
116,922 $1.18 Million
Q2 2018

Aug 14, 2018

SELL
$10.79 - $24.44 $435,969 - $987,498
-40,405 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$9.0 - $20.16 $363,645 - $814,564
40,405 New
40,405 $451,000

Others Institutions Holding OMER

About OMEROS CORP


  • Ticker OMER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,730,000
  • Market Cap $246M
  • Description
  • Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...
More about OMER
Track This Portfolio

Track Empire Life Investments Inc. Portfolio

Follow Empire Life Investments Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Empire Life Investments Inc., based on Form 13F filings with the SEC.

News

Stay updated on Empire Life Investments Inc. with notifications on news.